Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Tafenoquine in Patients With Mild to Moderate COVID-19

ClinicalTrials.gov ID: NCT04533347

Public ClinicalTrials.gov record NCT04533347. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:34 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind Placebo-controlled Study to Assess the Efficacy and Safety of Oral Tafenoquine Versus Placebo in Patients With Mild to Moderate COVID-19 Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A clinical study to assess the efficacy and safety of oral tafenoquine compared to placebo in patients with mild to moderate COVID 19 disease.

Study identification

NCT ID
NCT04533347
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
60 Degrees Pharmaceuticals LLC
Industry
Enrollment
86 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 19, 2021 (Actual)
Primary completion
Jun 30, 2022 (Actual)
Completion
Jun 30, 2022 (Actual)
Last update posted
Jan 7, 2025

2021 – 2022

United States locations

U.S. sites
10
U.S. states
5
U.S. cities
7
Facility City State ZIP Site status
Deluxe Health Center LLC Miami Florida 33014 —
Hope Clinical Trials Miami Florida 33165 —
F&T Medical Research, Inc. Miami Florida 33184 —
Kendall South Medical Center, Inc. Miami Florida 33185 —
Skyline Medical Center Elkhorn Nebraska 68022 —
Burke Primary Care Morgantown North Carolina 28655 —
AFC Urgent Care Easley South Carolina 29640 —
Centex Studies Brownsville Texas 78526 —
Care United Forney Texas 75126 —
Clinical Trial Network Houston Texas 77074 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04533347, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 7, 2025 · Synced Nov 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04533347 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →